Two cell culture flasks in a laboratory safety cabinet
    Regenerative Therapy

    MUSE Cells vs iPS Cells and How They Differ

    November 5, 202610 min read

    Is a MUSE Cell or an iPS Cell Safer and More Practical?

    Patients often hear about iPS cells in the news and MUSE cells from clinics, and ask which is better. The honest answer is that they are different tools with different risks. Comparing MUSE cells vs iPS cells starts with where each comes from.

    How MUSE Cells and iPS Cells Differ in Origin

    iPS cells: Takahashi and Yamanaka showed in 2006 that adding four factors (Oct3/4, Sox2, c-Myc and Klf4) could reprogramme mouse fibroblasts into pluripotent cells. The cells are made in a laboratory.

    MUSE cells: Kuroda and colleagues described them in 2010 as a small, stress-tolerant population within adult mesenchymal cells, identified by the marker SSEA-3. They already exist in the body and are collected, not created.

    Wakao and colleagues later reported that in human fibroblasts, iPS cells arose mainly from the MUSE cell fraction.

    MUSE Cells vs iPS Cells Side by Side

    ConsiderationiPS cellsMUSE cells
    OriginCreated by reprogramming adult cellsNaturally occurring, collected from tissue
    Genetic changeReprogramming factors introducedNo genetic modification
    Teratoma concernUndifferentiated cells can form teratomasNo teratomas in the original mouse testis tests
    Preparation before useUsually differentiated into a target cell firstGiven intravenously in published early studies
    Donor matchingDepends on the programmeEarly studies used donor cells without HLA matching or immunosuppressants
    Clinical statusInvestigational for most usesInvestigational, early-phase studies

    How MUSE Cells and iPS Cells Differ in Safety

    For iPS-based products, the main questions are whether any undifferentiated cells remain and whether reprogramming changed the genome. For MUSE products, the questions focus on donor screening, immune tolerance over time and product consistency.

    A lower tumour concern in animal tests does not prove long-term human safety. Our MUSE safety guide covers this in more detail.

    MUSE Cell Therapy Approach Compared With iPS Cells

    • How it works: MUSE cells are proposed to home to damaged tissue after intravenous infusion. This is under investigation.
    • Who may be suitable: only people matching a specific study or regulated pathway for their condition.
    • What a session involves: published studies used intravenous infusion with medical monitoring and follow-up.
    • Limits: early-phase evidence in a few conditions only. It is not a substitute for proven care.

    See condition studies on stroke, heart attack, epidermolysis bullosa and liver cirrhosis. For broader background, read our types of stem cells guide, our article on preparing MSCs before treatment and the early question of MUSE cells and ear ringing.

    How to Tell a MUSE Product From an iPS Product

    • Is the cell naturally collected or reprogrammed?
    • Which tissue and donor does it come from?
    • What identity and sterility tests are on the release document? See how MUSE cells are quality tested.
    • Which published studies match my condition?

    Bottom line: MUSE and iPS cells differ in origin and risk profile. Neither is a proven routine treatment yet.

    Medical References

    Talk to a Doctor Before You Decide

    Bring the name of any cell product you have been offered. Our team can explain where it comes from and what evidence applies to it.

    Schedule a Consultation

    Frequently Asked Questions

    No. iPS cells are made by reprogramming ordinary cells with added factors. MUSE cells are a naturally occurring SSEA-3-positive population collected from tissues such as bone marrow.

    They carry different risks. Undifferentiated iPS cells can form teratomas, so they are turned into specific cell types first. MUSE cells did not form teratomas in the original mouse testis tests. Neither is a proven routine therapy.

    No. MUSE cells are collected and expanded without adding reprogramming genes. iPS cells are created by introducing reprogramming factors.

    Yes. Wakao and colleagues reported that in human fibroblasts, iPS cells were generated mainly from the MUSE cell population rather than from other cells.

    No. Both remain investigational for most conditions and should be used only within regulated studies or approved pathways.

    Related Articles